Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Vaginal Neoplasms × Pharmacogenomic Testing × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 3 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiation 2 Platinum 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Cyclophosphamide 2 Congresses as Topic 2 Brachytherapy 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 1,2-diaminocyclohexaneplatinum II citrate 2 alovudine 1 adavosertib 1 Vaccines, Synthetic 1 Sonazoid 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiosurgery 1 Magnetic Resonance Spectroscopy 1 Interleukin-2 1 Fondaparinux 1 Fluorodeoxyglucose F18 1 Fentanyl 1 Device Removal 1 Dehydroepiandrosterone 1 Bupropion 1 Bevacizumab 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡